Abbott, Fournier Drop Suit Over Generic TriCor

Law360, New York (February 17, 2011, 1:25 PM EST) -- Abbott Laboratories and Laboratoires Fournier SA have dropped their patent suit seeking to block Ranbaxy Laboratories Ltd. from marketing a generic version of their cholesterol drug TriCor, bringing an end to one of several suits over the drug.

Judge Garrett E. Brown Jr. signed off on the parties' joint stipulation of dismissal in the U.S. District Court for the District of New Jersey on Tuesday, clearing the way for the drug companies to drop their claims and counterclaims without prejudice and without admitting any liability....
To view the full article, register now.